Please note: AABB reserves the right to make updates to this program.
Wednesday, March 26, 2025
2:00 – 3:00 PM Eastern Time
Program Number: 25EL-517
Director/Moderator: Yvette Tanhehco, PhD, MD, MS, CABP, Medical Director, Cellular Therapy Laboratory, New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY
Speakers:
Cellular therapy products are cryopreserved and stored in liquid nitrogen freezers for subsequent transplantation into recipients. Storage duration is variable but is typically a few weeks to a few years. Unused products may continue to be stored for many decades after the recipient has been transplanted due to a lack of careful management of product inventory and storage capacity as well as the inability or unwillingness to enforce disposition agreements. Discarding products for recipients that are still alive or whose status is unknown is not an option which complicates inventory management. The goal of this eCast is to present strategies for optimizing cellular therapy product cryopreservation and storage. The logistical and legal considerations for implementing these various strategies will be discussed.
After participating in this educational activity, participants should be able to:
Registration includes access to both the live and on-demand version of this eCast.
If you are a facility interested in participating in this eCast, simply complete the Group Viewing registration form and AABB will provide detailed instructions to share with your team approximately one week prior to the live program (each team member to register for the program utilizing a promocode). For single viewers, simply click on the Register button below to register.
Please note: registration for the live eCast will close 1 hour prior to the eCast start time. If you register after this time, you will receive access to the on-demand eCast when it is available.
| Single Viewer | Register |
| Group Viewing | Register |
This activity is eligible for one (1) continuing education credit/contact hour for Physicians, Nurses (including California-based nursing professionals through CBRN), California Lab Personnel, Florida Lab Personnel and General Participation credit. AABB reserves the right to reduce or increase the number of credits granted based on the final activity duration. For more information on each credit type please visit our Continuing Education Credits webpage.
There is no financial support for this activity.
In support of improving patient care, this activity has been planned and implemented by the Association for the Advancement of Blood & Biotherapies (AABB) and CME Outfitters, LLC. CME Outfitters LLC. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME): CME Outfitters, LLC, designates this live activity for a maximum of one (1) AMA PRA Category 1 CreditTM. CME Outfitters, LLC, designates this enduring activity for a maximum of one (1) AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Claiming Credit
Live Activity - Upon completion of the live activity, you will receive instructions to complete your evaluation, which is necessary to claim credit and receive your certificate of attendance/completion (credit must be claimed by the date provided in the instructions). The evaluation can be found by logging into the AABB Education Platform.
Enduring Activity - Once the enduring (on-demand) program is available, you will receive instructions to access the AABB Education Platform. Upon completion of viewing the enduring activity, you will need to complete the evaluation, which is necessary to claim credit and receive your certificate of completion (credit must be claimed by the date provided in the AABB Education Platform).
Program & Credit Expiration Dates:
Disclosure Declaration
It is the policy of CME Outfitters, LLC, and the Association for the Advancement of Blood & Biotherapies to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that the presence of such relationships will have a negative impact on the presentations.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty, peer reviewers, and CME Outfitters, LLC. personnel are provided at the beginning of the program.
Brenda Alder works at Northside Hospital Atlanta as the Manager over Quality & Regulations for the Cellular Therapy Lab and six Tissue Banks, ensuring the hospital is compliant with standards and regulations pertaining to HCT/Ps. Mrs. Alder has worked >25 years qualifying and collecting cell therapy, cord and blood donors, processing & transplanting CT (cell therapy) / immune effector cell products and as a Specialist in Blood Banking for transfusion medicine. She serves on her hospital IRB and works daily onboarding new research protocols for biotherapies. Mrs. Alder helped pioneer the only certification program available for biotherapy professionals: CABP (Certified Advance Biotherapy Professionals) and is qualified as a CABP. Mrs. Alder is a committee member for the new Standards for Cell & Gene Therapy for Pharmacies and its associated Accreditation Committee with the Association for Advancement of Blood and Biotherapies (AABB). She is a past-Chair and current member of the CT Standards & Accreditation Program Committees, the uniform CT donor history questionnaire committee, and the Transfusion Transmitted Diseases (TTD) committee (since 1999). These committees work alongside FDA CBER liaisons in developing AABB CT standards to align with national regulations (FDA) and worldwide standards (AABB) related to biotherapies.
Dr. Yvette C. Tanhehco is an Associate Professor of Pathology and Cell Biology at Columbia University Irving Medical Center (CUIMC) and the Director of the Cellular Therapy Laboratory and Assistant Director of Transfusion Medicine at New York-Presbyterian Hospital/CUIMC. She obtained a Bachelor of Arts degree in Microbiology and Molecular and Cell Biology from Cornell University; a Doctor of Philosophy degree in viral oncology from Johns Hopkins University; a Medical degree from the University of Pittsburgh; and a Masters of Science degree in Translational Research from the University of Pennsylvania. She completed both her residency training in Clinical Pathology and fellowship training in Blood Banking/Transfusion Medicine at the Hospital of the University of Pennsylvania. Dr. Tanhehco’s clinical and research interests focus on cellular and gene therapies for sickle cell disease. She is particularly interested in strategies to optimize patients and procedures for apheresis collections of hematopoietic progenitor cells and mononuclear cells to minimize patient adverse events and improve cell yields for drug product manufacturing. She is also interested in blood donations, component manufacturing and transfusion.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
